RainDance Targeted Gene Panels Are in High Demand at Greenwood Genetic Center’s CAP/CLIA Lab At Greenwood Genetic Center (GGC), a South Carolina-based nonprofit medical genetics institute that offers clinical genetic services and diagnostic testing, a targeted panel analyzing genes co
Panel Pioneer: For Emory’s Madhuri Hegde, Gene Panel Tests Are a Good Fit for CLIA Lab At a time when many in the genomics community were betting that whole-genome sequencing would be the path forward in the clinic, Madhuri Hegde made a strategic decision to focus on gene panel
RainDance Targeted Sequencing and Digital PCR: ‘A Potential Game-Changer’ As Director of the West Midlands Regional Genetics Laboratory at Birmingham Women’s Hospital in England — the largest National Health Service genetics diagnostic laboratory, with 150 staff mem
Munich Scientists Design New Myeloid Malignancy Panel with RainDance Tech Scientists at a leading reference diagnostic laboratory in Germany have developed a panel of genes linked to myeloid malignancies for use with RainDance’s targeted sequencing technology At the MLL Munich Leukemi
AML Gene Panel Moves Targeted Sequencing Closer to Clinical Utility Memorial Sloan-Kettering’s Ross Levine is using a gene panel developed with RainDance to better understand leukemia and to stratify patient samples by predicted outcome. Ross Levine, an associate member of the Human O
Targeted Sequencing Offers a Leap Forward in Cancer Research UCSD researcher uses RainDance targeted sequencing of cancer hotspots to multiplex samples, boost sensitivity, specificity and utility, and dramatically lower per-sample costs. When translational genomics expert Olivier Hari
Hope from HOXB13, New Variant Implicated in Prostate Cancer Risk Advances in targeted sequencing technology help scientists track down a rare variant linked to significantly increased risk of prostate cancer. Scientists at the Translational Genomics Research Institute (TGen), the Univ
RainDance Technologies® is making complex genetics simple. The company’s ultra-sensitive genomic tools enable research of novel non-invasive liquid biopsy applications that should result in more accurate, reliable, cost-effective, and early detection of cancer and other inherited and infectious diseases. Major research institutions and laboratories around the world rely on the performance of RainDance systems. Based outside Boston, Massachusetts, the company supports customers using RainDrop® Digital PCR, as well as the ThunderStorm® and ThunderBolts™ Next-Generation Sequencing Enrichment Systems through its international sales and service operations, as well as a global network of distributors and commercial service providers. Both technology platforms have been recognized by The Scientist as Top 10 Innovations with the RainDrop System winning the award in 2014 and the ThunderStorm System winning the award in 2011.